0.40 USD
↘ 0.03 (7.99%)AT CLOSE (03:59 PM EDT)
Shares of Humacyte, Inc. Common Stock (HUMA) are trading at $0.40. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, HUMA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 26, 2026.